Trial record 1 of 1 for:    hepatocellular carcinoma sorafenib mFOLFOX
Previous Study | Return to List | Next Study

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01775501
Recruitment Status : Recruiting
First Posted : January 25, 2013
Last Update Posted : February 2, 2017
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2017
  Estimated Study Completion Date : May 2017